Publications by authors named "Peter Repiscak"

Claim this Profile
I
Image-based drug screening combined with molecular profiling identifies signatures and drivers of therapy resistance in pediatric AML.
Ben Haladik, Margarita Maurer-Granofszky, Peter Zoescher, Raul Jimenez-Heredia, Alexandra Frohne, Peter Repiscak

Cell Rep Med· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Natural Killer Cell-Mediated Cytotoxicity Shapes the Clonal Evolution of B-cell Leukemia.
Michelle C Buri, Mohamed R Shoeb, Aleksandr Bykov, Peter Repiscak, Hayeon Baik

Cancer Immunol Res· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biallelic NFATC1 mutations cause an inborn error of immunity with impaired CD8+ T-cell function and perturbed glycolysis.
Sevgi Kostel Bal, Sarah Giuliani, Jana Block, Peter Repiscak, Christoph Hafemeister

Blood· August 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Protocols for Understanding the Redox Behavior of Copper-Containing Systems.
Thomas Malcomson, Peter Repiščák, Stefan Erhardt, Martin J Paterson

ACS Omega· December 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Multi-omics & pathway analysis identify potential roles for tumor N-acetyl aspartate accumulation in murine models of castration-resistant prostate cancer.
Mark J Salji, Arnaud Blomme, J Henry M Däbritz, Peter Repiscak, Sergio Lilla

iScience· April 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
THEM6-mediated reprogramming of lipid metabolism supports treatment resistance in prostate cancer.
Arnaud Blomme, Coralie Peter, Ernest Mui, Giovanny Rodriguez Blanco, Ning An, Peter Repiscak

EMBO Mol Med· March 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Germline biallelic mutation affecting the transcription factor Helios causes pleiotropic defects of immunity.
Tala Shahin, Hye Sun Kuehn, Mohamed R Shoeb, Lisa Gawriyski, Sarah Giuliani, Peter Repiscak

Sci Immunol· November 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Landscape of Bone Marrow Metastasis in Human Neuroblastoma Unraveled by Transcriptomics and Deep Multiplex Imaging.
Daria Lazic, Florian Kromp, Fikret Rifatbegovic, Peter Repiscak, Michael Kirr

Cancers (Basel)· August 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
In vivo CRISPR/Cas9 knockout screen: TCEAL1 silencing enhances docetaxel efficacy in prostate cancer.
Linda K Rushworth, Victoria Harle, Peter Repiscak, William Clark, Robin Shaw

Life Sci Alliance· December 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
1
18F-Fluciclovine PET metabolic imaging reveals prostate cancer tumour heterogeneity associated with disease resistance to androgen deprivation therapy.
Gaurav Malviya, Rachana Patel, Mark Salji, Rafael S Martinez, Peter Repiscak

EJNMMI Res· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
2
2,4-dienoyl-CoA reductase regulates lipid homeostasis in treatment-resistant prostate cancer.
Arnaud Blomme, Catriona A Ford, Ernest Mui, Rachana Patel, Chara Ntala, Peter Repiscak

Nat Commun· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Correction: BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration.
Carolyn J Loveridge, Sarah Slater, Kirsteen J Campbell, Noor A Nam, John Knight, Peter Repiscak

Oncogene· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Activation of β-Catenin Cooperates with Loss of Pten to Drive AR-Independent Castration-Resistant Prostate Cancer.
Rachana Patel, Elspeth A Brzezinska, Peter Repiscak, Imran Ahmad, Ernest Mui

Cancer Res· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
BRF1 accelerates prostate tumourigenesis and perturbs immune infiltration.
Carolyn J Loveridge, Sarah Slater, Kirsteen J Campbell, Noor A Nam, John Knight, Peter Repiscak

Oncogene· February 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Metformin selectively targets redox control of complex I energy transduction.
Amy R Cameron, Lisa Logie, Kashyap Patel, Stefan Erhardt, Sandra Bacon

Redox Biol· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sprouty2 loss-induced IL6 drives castration-resistant prostate cancer through scavenger receptor B1.
Rachana Patel, Janis Fleming, Ernest Mui, Carolyn Loveridge, Peter Repiscak

EMBO Mol Med· April 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
General Force-Field Parametrization Scheme for Molecular Dynamics Simulations of Conjugated Materials in Solution.
Jack Wildman, Peter Repiščák, Martin J Paterson, Ian Galbraith

J Chem Theory Comput· August 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sleeping Beauty screen reveals Pparg activation in metastatic prostate cancer.
Imran Ahmad, Ernest Mui, Laura Galbraith, Rachana Patel, Ee Hong Tan, Peter Repiscak

Proc Natl Acad Sci U S A· July 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
B
Biomolecular mode of action of metformin in relation to its copper binding properties.
Peter Repiščák, Stefan Erhardt, Graham Rena, Martin J Paterson

Biochemistry· February 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis